Lawrence David Mayer

Lawrence David Mayer appears in our data through filings on Celator Pharmaceuticals Inc shares, published by SEC (Form 4). In total, 9 filings cover trades dated from 6 November 2013 to 12 July 2016.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 12 July 2016: a transaction of €2.9M, in Celator Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.